Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock

Completed · Early Phase 1 · Has a placebo group

Conditions studied: Aging, Epigenetics, Inflammatory Mediators

In brief

Topical Rapamycin ointment will be applied to participant forearms to test whether epigenetic changes in the skin are elicited.

Key facts

Study ID
NCT04608448
Run by
The University of Texas Health Science Center at San Antonio
People needed
22
Starts
2021-04-28
Expected to finish
2022-04-15
Last updated by the study team
2023-07-19

Who can join

Age: 65 and older, up to 95. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.